New Drug Target Could Prevent Deadly Blood Clots in Autoimmune Disease
Scientists discover how blocking CD40-CD40L pathway reduces dangerous clotting in antiphospholipid syndrome patients.
Autoimmune diseases, immune modulation, inflammation, and self-tolerance
169 articles
Scientists discover how blocking CD40-CD40L pathway reduces dangerous clotting in antiphospholipid syndrome patients.
Advanced photon-counting CT technology reveals arterial inflammation in giant cell arteritis with superior clarity.
New study shows 84% of RA patients can discontinue prednisolone after short-term use, supporting safer treatment approaches.
Researchers discuss anifrolumab as potential second-line treatment for childhood lupus when belimumab doesn't work.
Scientists discover how defective gene splicing in neutrophils contributes to lupus severity and immune dysfunction.
Monitoring IgG protein levels during first year of treatment can predict which patients will experience disease relapse.
Case report reveals dangerous skin complications in rheumatoid arthritis patients that doctors need to recognize early.
New research reveals how IL-17 triggers inflammatory cascades that damage blood vessels in giant cell arteritis patients.
Researchers identify OGFRL1 gene deficiency as a novel cause of chronic bone disease, with promising treatment response to TNF inhibitors.
New clinical insights into treating Rowell syndrome, a rare skin manifestation affecting lupus patients with serious complications.
Revolutionary cell therapy achieves drug-free remission in patients with severe myasthenia gravis, an autoimmune muscle disorder.
Systematic review reveals younger RA patients achieve higher remission rates and better outcomes with biologic therapies than older patients.